Toutes les études
RecrutementPHASE4INTERVENTIONNEL

Staphylococcus Aureus Network Adaptive Platform Trial

The SNAP trial is looking into better ways to treat a serious blood infection caused by a germ called Staphylococcus aureus (S. aureus), also known as SAB. This infection can be very dangerous, and sadly, some people don't survive. Doctors currently use different ways to treat it, but aren't sure which is most effective. This study will test several existing treatments to see which ones save the most lives within 90 days. Unlike traditional studies, SNAP can change as it goes along, focusing more on treatments that seem to work better and removing those that don't. This helps ensure patients receive the most promising care and helps doctors quickly learn the best ways to treat this infection.

En un coup d'œil

Statut
Recrutement
Phase
PHASE4
Sponsor
University of Melbourne
Objectif d'inscription
8,000
Démarrer
16 Feb 2022
Achèvement estimé
01 Déc 2028

De quoi parle cette étude ?

The Staphylococcus aureus Network Adaptive Platform (SNAP) trial is a really important study looking for better ways to treat a serious blood infection. This infection is caused by a germ called Staphylococcus aureus, which doctors often shorten to S. aureus or SAB. When S. aureus gets into your bloodstream, it can be very dangerous and can lead to serious health problems, and sadly, some patients don't survive.

Currently, there are several ways doctors treat S. aureus blood infections, but they don't have a clear idea of which treatment plan is the best. The SNAP trial wants to change that. It's designed to compare different treatments to find out which ones lead to the best results, specifically looking at which treatments help the most patients survive the first 90 days after getting the infection.

What's special about the SNAP trial is that it's 'adaptive.' This means that as the study goes on and doctors learn more about which treatments are working better, they can adjust the trial. They can give more patients the treatments that seem more effective and stop using treatments that aren't working as well. They can also add new treatments if they look promising. This smart approach helps ensure that patients in the trial get the best possible care based on the latest information, and it helps doctors quickly figure out the most effective ways to fight this infection.

Points clés

  • The SNAP trial studies treatments for a serious blood infection (S. aureus).
  • It aims to find the best treatments to improve survival.
  • The study is 'adaptive', meaning it learns and adjusts as it goes.
  • All treatments are existing medicines, not experimental ones.
  • Participation could help uncover better future treatments for this infection.

Qui peut être éligible ?

To join the main part of this study, you would need to have a Staphylococcus aureus germ found in at least one of your blood tests. You also need to be a patient in a hospital taking part in the study. If you've sadly passed away, but were in a participating hospital when your blood sample was taken, your medical information might still be included in the study.

However, there are reasons why you might not be able to join. For example, if it's been more than 72 hours (3 days) since your blood test was taken, or if other germs are found in your blood at the same time as S. aureus. You also can't join if you've already been part of this specific trial before, or if your medical team feels that joining wouldn't be in your best interest due to other serious health concerns or if you are receiving end-of-life care. Patients under 18 years old can only join if the hospital has special approval for younger patients.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Do you have Staphylococcus aureus found in your blood?
  2. Are you currently an inpatient at a hospital participating in this study?
  3. Is it less than 3 days since your blood sample was taken?
  4. Do you have only S. aureus in your blood, and no other serious infections there?
  5. Are you aged 18 or over (unless your hospital has approval for younger patients)?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you are asked to join the SNAP trial, you'll be assigned by chance to one of the different treatment groups. These treatments are all ones that doctors already use. You'll receive your antibiotics, likely through an drip into your vein while you're in the hospital. The study team will closely monitor your health and recovery while you are receiving treatment and thereafter. They will review your medical information to see how well the treatment is working. The SNAP trial aims to find the most effective treatments for S. aureus blood infections to improve patient outcomes.

Risques et avantages potentiels

Taking part in this study could help doctors learn which treatments for S. aureus blood infections are most effective, potentially helping you and many future patients. All treatments used are already part of standard medical care, so you wouldn't be receiving an experimental drug. However, as with any medical treatment, there can be side effects, and your doctor will discuss these with you. You are free to withdraw from the study at any time without it affecting your medical care.

Locations (161)

  • Houston Methodist Research Institute
    Code postal vérifié
    Houston, États-Unis· Recrutement
  • Canberra Hospital
    Code postal vérifié
    Garran, Australia· Recrutement
  • Blacktown Hospital
    Code postal vérifié
    Blacktown, Australia· Recrutement
  • Royal Prince Alfred Hospital
    Code postal vérifié
    Camperdown, Australia· Recrutement
  • Concord Repatriation and General Hospital
    Code postal vérifié
    Concord, Australia· Recrutement
  • St Vincent's Hospital Sydney
    Code postal vérifié
    Darlinghurst, Australia· Recrutement
  • Nepean Hospital
    Code postal vérifié
    Kingswood, Australia· Recrutement
  • St George Hospital
    Code postal vérifié
    Kogarah, Australia· Pas encore en recrutement
  • Liverpool Hospital
    Code postal vérifié
    Liverpool, Australia· Recrutement
  • John Hunter Hospital
    Code postal vérifié
    New Lambton Heights, Australia· Recrutement
  • John Hunter Children's Hospital
    Code postal vérifié
    Newcastle, Australia· Recrutement
  • Orange Health Service
    Code postal vérifié
    Orange, Australia· Recrutement

Questions fréquentes

What is Staphylococcus aureus (S. aureus) blood infection?

It's a serious infection where a common germ called Staphylococcus aureus gets into your bloodstream. It can make you very unwell.

What does 'adaptive platform trial' mean?

It's a smart study design that can change as it goes along. Doctors can learn from early results and focus more on treatments that are working best, or remove those that aren't.

Will I get a new or experimental medicine?

No, all the treatments being tested in this study are medicines already used by doctors. The study is comparing them to find out which works best.

Combien de temps vais-je participer à l'étude ?

The study will look at how you are doing for 90 days after your infection. Your medical team will monitor you during this time.

Can I choose my treatment?

No, if you join, you will be randomly assigned to one of the established treatment options. This helps ensure fair testing of each treatment.

Comment en savoir plus

Lauren Barina

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Staphylococcus Aureus Network Adaptive Platform Trial… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.